跳至主要内容
临床试验/IRCT20181014041338N1
IRCT20181014041338N1招募中未知

Comparison between the effect of carbamazepine and levetiracetam usage in the treatment of children between 6 to 12 years old with Rolandic epilepsy; An open-labeled RCT

Shiraz University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • children between age 6-12 years old (age of onset of disorder and eligible for the cognitive test)
  • diagnosed with Rolandic syndrome by using vEEG or EEG by a pediatric neurologist or epileptologist
  • having no previous history of using AEDs (Anti-epileptic drugs)
  • having no previous history of neurological and/or psychiatric and/or learning and/or genetical disorder(s) previous to the onset of Rolandic syndrome
  • having no history of using drugs that affect cognitive abilities significantly
  • signing ethical consent with total awareness and voluntary

排除标准

  • patients who showed any side effects of Carbamazepine (like skin rash, Steven Johnson) and Levetiracetam (like suicide thoughts, acute behavioral problems due to Levetiracetam usage)

研究者

相似试验

Comparison between the effect of carbamazepine and... | 临床试验